Palomino Laboratories (PALX) Equity Ratio (2022 - 2025)
Palomino Laboratories recorded quarterly Equity Ratio of 0.96 in Q4 2025, up 9.13% quarter-over-quarter from 0.88 in Q3 2025, and up 824.43% year-over-year from 0.1 in Q4 2024.
Palomino Laboratories' Equity Ratio history runs 4 years deep, the most recent figure standing at 0.96 for Q4 2025.
- In Q4 2025, Equity Ratio rose 824.43% year-over-year to 0.96; the TTM figure through Dec 2025 stood at 0.96 (up 824.43% YoY), while the FY2025 annual figure was 0.96, up 824.43% from the prior year.
- Equity Ratio came in at 0.96 for Q4 2025 at Palomino Laboratories, up from 0.88 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.96 in Q4 2025 to a low of 237.01 in Q2 2025.
- A 4-year average of 58.08 and a median of 25.91 in 2024 frame the typical range for Equity Ratio.
- On a YoY basis, Equity Ratio climbed as much as 824.43% in 2025 and fell as far as 3698.75% in 2025.
- Palomino Laboratories' Equity Ratio stood at 55.61 in 2022, then rose by 13.37% to 48.17 in 2023, then jumped by 99.72% to 0.13 in 2024, then soared by 824.43% to 0.96 in 2025.
- According to Business Quant data, Equity Ratio over the past three periods registered 0.96, 0.88, and 237.01 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.96 |
| Sep 30, 2025 | 0.88 |
| Jun 30, 2025 | -237.01 |
| Mar 31, 2025 | -54.43 |
| Dec 31, 2024 | -0.13 |
| Sep 30, 2024 | -25.91 |
| Jun 30, 2024 | -6.24 |
| Mar 31, 2024 | -6.20 |
| Dec 31, 2023 | -5.55 |
| Sep 30, 2023 | -207.02 |
| Dec 31, 2022 | -55.61 |